Search - tctmd.com

Displaying 301 - 320 of 546

Sort: Relevancy | Date

News Industry News

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

November 30, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Daily News

PAD 患者按计划锻炼之余接受血管内治疗的效果更好

Caitlin E. Cox

November 15, 2015

News Daily News

PAD Patients Do Better When Endovascular Therapy Added to Exercise Program

Caitlin E. Cox

November 15, 2015

News Daily News

A los Pacientes EAP les Va mejor cuando el Tratamiento Endovascular se Suma a un Programa de Ejercicio Físico

Caitlin E. Cox

November 15, 2015

News Industry News

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

November 02, 2015

News Daily News

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

L.A. McKeown

October 26, 2015

News Daily News

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

L.A. McKeown

October 26, 2015

News Daily News

DCB治疗膝下病变又传出令人失望的消息

L.A. McKeown

October 26, 2015

Presentation

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

Presenter: Thomas Zeller

October 23, 2015

News Daily News

观察性研究揭示了血管内和手术方案在治疗症状性 PAD 时的差异

L.A. McKeown

October 05, 2015

News Daily News

Un Estudio observacional Arroja Luz sobre las Opciones Endovascular y Quirúrgica para la EAP Sintomática

L.A. McKeown

October 05, 2015

News Daily News

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

L.A. McKeown

October 05, 2015

Presentation

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

Presenter: Thomas T. Tsai

October 02, 2015

News Industry News

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

September 30, 2015

News Industry News

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

September 29, 2015

News Daily News

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

L.A. McKeown

September 23, 2015

News Daily News

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

L.A. McKeown

September 23, 2015

News Daily News

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

L.A. McKeown

September 23, 2015

Presentation

3-year Outcomes of the OLIVE Registry: A Prospective Multicenter Study of CLI

Presenter: O. Iida

September 22, 2015

Advertisement

Boston Scientific Receives FDA Approval And CE Mark For AngioJet™ ZelanteDVT™ Thrombectomy Catheter

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

PAD 患者按计划锻炼之余接受血管内治疗的效果更好

PAD Patients Do Better When Endovascular Therapy Added to Exercise Program

A los Pacientes EAP les Va mejor cuando el Tratamiento Endovascular se Suma a un Programa de Ejercicio Físico

REALITY Study to Evaluate Use of Directional Atherectomy and Drug Coated Balloon in Patients with Peripheral Arterial Disease

More Discouraging News for DCBs in Treatment of Infrapopliteal Lesions

Más Noticias Desalentadoras para los BRFs en el Tratamiento de Lesiones Infrapoplíteas

DCB治疗膝下病变又传出令人失望的消息

Paclitaxel-Coated Balloon in Infrapopliteal Arteries

观察性研究揭示了血管内和手术方案在治疗症状性 PAD 时的差异

Un Estudio observacional Arroja Luz sobre las Opciones Endovascular y Quirúrgica para la EAP Sintomática

Observational Study Sheds Light on Endovascular vs Surgical Options for Symptomatic PAD

Lower Extremity Bypass Surgery and Peripheral Endovascular Interventions for Symptomatic PAD

Intact Vascular Announces Conditional FDA Approval for Tack Optimized Balloon Angioplasty II (TOBA II) Study and Enrollment of First Patients

STENTYS Receives CE Mark for Self-Apposing Stent in Lower Limb Artery Disease

Registro OLIVE: ‘Razonables’ Resultados del Tratamiento Endovascular para el Manejo de la ICE a los 3 Años

OLIVE登记处：3年时的CLI血管内临床治疗结果“合情合理”

OLIVE Registry: Endovascular Therapy Outcomes for CLI ‘Reasonable’ at 3 Years

3-year Outcomes of the OLIVE Registry: A Prospective Multicenter Study of CLI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content